Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic alterations and hepatitis C: From bench to bedside.

World journal of gastroenterology - 28 Jan 2016

Chang Ming-Ling

Abstract excerpt

In addition to causing cirrhosis and hepatocellular carcinoma, hepatitis C virus (HCV) is thought to cause hypolipidemia, hepatic steatosis, insulin resistance, metabolic syndrome, and diabetes. The viral life cycle of HCV depends on cholesterol metabolism in host cells. HCV core protein and nonstructural protein 5A perturb crucial lipid and glucose pathways, such as the sterol regulatory element-binding protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Dyslipidemias
Share to Energy Metabolism

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Fatty Liver

Share to Glucose

Share to Host-Pathogen Interactions

Share to Lipid Metabolism

Share to Metabolic Syndrome

Source

Open in PubMed Open full text

Identifiers

PMID: 26819514
DOI: 10.3748/wjg.v22.i4.1461
PMCID: PMC4721980

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic alterations and hepatitis C: From bench to bedside.PMID 26819514Read ↗

Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies.Semantic proximity Read ↗

Steatosis and insulin resistance in hepatitis C: a way out for the virus?Semantic proximity Read ↗

Hepatitis C and steatosis.Semantic proximity Read ↗

Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond.Semantic proximity Read ↗

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic StrategiesSemantic proximity Read ↗

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.Semantic proximity Read ↗

Genotype 3 Infection: The Last Stand of Hepatitis C Virus.Semantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.Semantic proximity Read ↗

The cell biology of hepatitis C virus (HCV) lipid addiction: molecular mechanisms and its potential importance in the clinic.Semantic proximity Read ↗

Global molecular landscape of early MASLD progression in obesitySemantic proximity Read ↗

Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.